These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34434613)

  • 1. Managing Risks Due to Ingredient Variability in Food Production.
    Riddick F; Wallace E; Davis J
    J Res Natl Inst Stand Technol; 2016; 121():17-32. PubMed ID: 34434613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
    Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
    PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Analysis of Technologies and Standards for Designing Smart Manufacturing Systems.
    Choi S; Jung K; Kulvatunyou B; Morris KC
    J Res Natl Inst Stand Technol; 2016; 121():422-433. PubMed ID: 34434632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: A Literature Review.
    Jenke DR; Stults CL; Paskiet DM; Ball DJ; Nagao LM
    PDA J Pharm Sci Technol; 2015 1/2; 69(1):1-48. PubMed ID: 25691713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
    Steinwandter V; Herwig C
    PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluent.
    Caldwell DJ; Mertens B; Kappler K; Senac T; Journel R; Wilson P; Meyerhoff RD; Parke NJ; Mastrocco F; Mattson B; Murray-Smith R; Dolan DG; Straub JO; Wiedemann M; Hartmann A; Finan DS
    Environ Toxicol Chem; 2016 Apr; 35(4):813-22. PubMed ID: 26183919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
    Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
    Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Justification of a Risk Evaluation Matrix To Guide Chemical Testing Necessary To Select and Qualify Plastic Components Used in Production Systems for Pharmaceutical Products.
    Jenke D
    PDA J Pharm Sci Technol; 2015; 69(6):677-712. PubMed ID: 26659101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future.
    Arden NS; Fisher AC; Tyner K; Yu LX; Lee SL; Kopcha M
    Int J Pharm; 2021 Jun; 602():120554. PubMed ID: 33794326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.
    Chinery L; Allaouidine C; Tomazzini A; Larson M; Gülmezoglu AM
    Reprod Health; 2020 Nov; 17(1):171. PubMed ID: 33148282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOSS-Multi-Modal Best Subset Modeling in Smart Manufacturing.
    Wang L; Du P; Jin R
    Sensors (Basel); 2021 Jan; 21(1):. PubMed ID: 33401493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients.
    Malwade CR; Qu H
    Curr Pharm Des; 2018; 24(21):2456-2472. PubMed ID: 29956616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-839. PubMed ID: 28756845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade
    Melsheimer R; Calmann M; DeRitis A; Philip V; Van Gog F; Doolittle L; Goyal K; Neblock D
    BioDrugs; 2018 Oct; 32(5):405-414. PubMed ID: 30143982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioprocesses for the manufacture of ingredients for foods and cosmetics.
    Cheetham PS
    Adv Biochem Eng Biotechnol; 2004; 86():83-158. PubMed ID: 15088764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. System Interdependency Modeling in the Design of Prognostic and Health Management Systems in Smart Manufacturing.
    Malinowski ML; Beling PA; Haimes YY; LaViers A; Marvel JA; Weiss BA
    Proc Annu Conf Progn Health Manag Soc; 2015; 6():038. PubMed ID: 28664162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.